Brief: Biomed Lublin Signs EUR Up To 9.0 Mln Loan Deal For Strategic Investments Financing

Synthaverse SA

09/11/2022 07:00

Nov 9 (Reuters) - Biomed-Lublin Wytwórnia Surowic I
Szczepionek SA  BML.WA :
    * SAID ON TUESDAY, IT HAS SIGNED A LOAN DEAL WITH ACP CREDIT
I SCA
SICAV-RAIF (ACP) FOR UP TO EUR 9.0 MILLION, IN CONNECTION TO THE
GROWTH STRATEGY UPDATE THE COMPANY HAD ADOPTED ON NOVEMBER 2
    * UNDER DEAL THE LOAN AMOUNT MAY BE INCREASED TO TOTAL VALUE
OF
EUR 13.0 MILLION
    * SAID LOAN IS FOR REFINANCING PURPOSES AND DEBT
CONSOLIDATION,
WHICH WILL BE ALLOCATED FOR THE FINANCING OF STRATEGIC
INVESTMENT OF ONKO BCG PRODUCTION PLANT AND R&D CENTER
    * THE DEAL WITH ACP REPLACES DEBT FINANCING GRANTED BY
AGENCJA
ROZWOJU PRZEMYSLU
    * PARTIES AGREED TO SET FINANCING PERIOD UNTIL END OF 2029
WITH
REPAYMENTS TO COMMENCE FROM END OF 2026

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM837v3ha
 Further company coverage:  BML.WA  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))